Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-10-17
2009-12-15
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S015800, C530S327000, C530S328000
Reexamination Certificate
active
07632817
ABSTRACT:
Peptide or pseudopeptide decoys binding to antibodies capable of being developed against endogenous proteins within the framework of autoimmune pathologies or against exogenous proteins administered to patients, in particular within the framework of pathologies due to a deficiency in these proteins, the amino acid sequence of the peptide or pseudopeptide decoys differing from that of the epitopes recognized by the antibodies, for the preparation of medicaments intended for the prevention or treatment of the autoimmune pathologies, or for the prevention or treatment of the disorders linked to the appearance of antibodies directed against the exogenous proteins.
REFERENCES:
patent: 5187155 (1993-02-01), Fair
patent: 5846933 (1998-12-01), Korngold et al.
patent: 6043220 (2000-03-01), Chang et al.
patent: 96/02572 (1996-02-01), None
patent: 98/33920 (1998-08-01), None
patent: 99/30736 (1999-06-01), None
patent: 99/46274 (1999-09-01), None
patent: 99/47932 (1999-09-01), None
patent: 00/40602 (2000-07-01), None
U.S. Departmetn of Health and Human Services, Office of Women's Health. Autoimmune Diseases: Overview. pp. 1-6. Jan. 2005.
Rudinger, J (1976). Peptide Hormones (Ed. J.A. Parson). University Park Press. baltomre pp. 1-7.
Bellone et al. ‘Cancer Immunotherapy: Synthetic and Natural Peptides in the Balance’ Immunol Today. Oct. 1999;20(10):457-62.
Bradley et al. ‘Limits of Cooperativeity in a Structurally Modula Protein: Response of the Notch Ankyrin Domain to Analogous Alanine Substitution in Each Repeat.’ J. Mol. Biol. vol. 324, pp. 373-386 2002.
Vandenbark et al. ‘TCR Peptide Therapy in Human Autoimune Diseases’ Neurochemcial Research, vol. 26, No. 6, pp. 713-730. 2001.
Lim et al. ‘Allelic Avation of MHC Structure Allters Peptide Ligands to Induce Atypical Partial Agonistic CD8+ T Cell Function.’ J. of Exper. Med. vol. 198, No. 1, pp. 99-109. Jul. 2003.
Steinman et al. ‘How to Successfully Apply Animal Studies in Experimental Allergic Encephalomyelitis to Research on Multple Sclerosis’ Ann Neurol. vol. 60, pp. 12-21. 2006.
Ngo et al. “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox.” TheProtein Folding Problem and Tertiary structure Prediction. Ed. K. Merz and L. Le Grand. Birkhauser, Boston, Ma. 491-495.
Berendsen, Herman. “A Glimpse of the Holy Grail?” Science, vol. 282, pp. 642-643. Oct. 23, 1998.
McConnell, S J et al., “Constrained peptide libraries as a tool for finding mimotopes” Gene, vol. 151, Dec. 30, 1994, pp. 115-118.
Sem, D S et al., “Structural characterization and optimization of antibody-selected phage library mimotopes of an antigen associated with autoimmune recurrent thrombosis” Biochemistry, vol. 37, No. 46, Nov. 17, 1998, pp. 16069-16081.
Nogami et al., “Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: Requirement of Cys2326 and Glu2327 for maximum effect.” British Journal of Haematology, vol. 107, No. 1, Oct. 1999 , pp. 196-203, XP009008081 ISSN: 0007-1048.
Kuwabara et al., “Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients,” Journal of Immunological Methods, Elsevier Science Publishers B.V., Amsterdam, NL, vol. 224, No. 1-2, Apr. 22, 1999 , pp. 89-99, XP004165513 ISSN: 0022-1759.
Voorberg et al., “Phage display technology: A tool to explore the diversity of inhibitors to blood coagulation factor VIII.” Seminars in Thrombosis and Hemostasis, vol. 26, No. 2, pp. 143-150, XP008005330 ISSN: 0094-6176.
Ferrieres et al. “Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display: Role of sequences flanking the binding motif.” European Journal of Biochemistry, vol. 267, No. 6, Mar. 2000 , pp. 1819-1829, XP001093880 ISSN: 0014-2956.
Takahaashi et al. “Change of Antigenic and Neutralizing specificity in Substitutional epitope peptides of hemophilia B inhibitor” Peptides, Elmsford, US, vol. 19, No. 7, 1998, pp. 1129-1136, XP001037525 ISSN: 0196-9781.
McConnell et al. “Constrained peptide libraries as a tool for finding mimotopes” Gene, Elsevier Biomedical Press. Amsterdam, NL, vol. 151, No. 1, Dec. 30, 1994, pp. 115-118, XP004042621 ISSN: 0378-1119.
Sibille et al. “Mimotopes of Po;yreactive Anti-DNA Antibodies identified Using Phage-Display Peptide Libraries”, European Journal of Immunology, Weinheim, DE, vol. 27, May 1997, pp. 1221-1228, XP000973084 ISSN: 0014-2980.
Doudna et al. “Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, US, vol. 92, No. 6, Mar. 14 (1995), pp. 2355-2359, XP000919062 ISSN: 0027-8424.
Vanhoorelbeke et al. “Sequence alignment between VWF and peptide inhibiting the VWF-collagen interaction does not result in the identification of a collagen-binding site in VWF” Thrombosis and Haemostasis, Stuttgart, DE, vol. 84, No. 4, Oct. 2000, pp. 621-625, XP008006899 ISSN: 0340-6245.
Suphioglu et al. “A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction” FEBS Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 502, No. 1-2, July 27, 2001, pp. 46-52, XP004296817 ISSN: 0014-5793.
Sem et al. “Structural characterization and optimization of antibody-selected phage library mimotopes of an antigen associated with autoimmune recurrent thrombosis.” Biochemistry. United States Nov. 17, 1998, vol. 37, No. 46, Nov. 17, 1998, pp. 16069-16081, XP002245692 ISSN: 0006-2960.
Granier Claude
Villard Sylvie
Centre National de la Recherche Scientifique
Gupta Anish
Young & Thompson
LandOfFree
Peptide decoys for the preparation of medicaments intended... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide decoys for the preparation of medicaments intended..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide decoys for the preparation of medicaments intended... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4089616